http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105219833-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 |
| filingDate | 2015-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105219833-B |
| titleOfInvention | A kind of primary liver cell Pharmaceutical Analysis kit of animal and its application |
| abstract | The present invention relates to a kind of primary liver cell Pharmaceutical Analysis kit of animal and its application.The technical solution of use is：The primary liver cell Pharmaceutical Analysis kit original cuiture liver cell of animal, DMEM complete mediums, substrate buffer solution, NAD+ solution and 2,4 dinitro benzene hydrazine solutions are formed, which can be used for damage of the analysis medicine to liver cell.The present invention can provide a kind of method for efficiently separating primary liver cell and the kit as Pharmaceutical Analysis, it is primary that to be separately cultured liver cell easily adherent, culture liver cell state is good after recovery, and kits work well, can be as judging medicine to one of foundation of hepatocellular injury.It the composite can be widely applied to the exploration of liver physiology function, the research of cell pathology, pharmacology and toxicology mechanism, and the detection of newtype drug hepatotoxicity. |
| priorityDate | 2015-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 146.